While sticking to our strengths and prioritizing our strategic approaches based on the principles and frameworks discussed in this strategy, we will be proactive in identifying opportunities where our activities can contribute to building country resilience to four important global health challenges:
Implementation research is crucial to strategies for prevention, preparedness and response in the face of public health outbreaks and emergencies. The succession of global public health emergencies the world has experienced in recent years is likely to continue, and epidemic threats remain inevitable, with potential for added reversal of public health gains, as witnessed with Ebola, Zika and COVID-19. New and improved tools, approaches and interventions are required to detect and counteract emerging infectious disease threats and population vulnerabilities early. We will support the generation of evidence that strengthens epidemic preparedness and the resilience of health systems to minimize the impact on existing programmes such as established vaccination measures. We will also support research that informs equitable and inclusive health system responses to epidemics and outbreaks, which reach the most vulnerable populations and leave no one behind. This will strengthen health security for all.
TDR has been establishing and/or strengthening countries’ capacities to identify signals of an impending dengue outbreak. This has led to the development of an Early Warning and Response System. We are currently supporting two countries, Colombia and Thailand, which were selected through an open call to evaluate the feasibility and effectiveness of using the system for predicting dengue outbreaks and implementing early response.
Tuberculosis, malaria and neglected tropical diseases disproportionally affect the poorest and most vulnerable. TDR will support research that leads to integrated, holistic approaches to elimination – reducing the burden of disease and building resilient health systems.
We support work that crosses the disciplines of human, animal and environmental health and promote the importance of applying an intersectional gender lens to infectious disease research.
TDR is committed to supporting the implementation of WHO’s road map for neglected tropical diseases 2021–2030. In particular, TDR-supported research on visceral leishmaniasis and onchocerciasis have contributed to major milestones toward elimination.
Climate change and loss of biodiversity affect the epidemiology of infectious diseases – altering drivers of disease, risks to populations and the effectiveness of control programmes. TDR will support research through a One Health approach to better understand these changes and inform adaptation strategies.
Over the last few years, TDR has been developing and piloting a framework for operationalizing a One Health approach to tackling vector-borne diseases in the context of climate change in Africa. TDR, WHO’s Department of Control of Neglected Tropical Diseases and the Climate, Health and Environment team at the WHO Regional Office for Africa are now supporting four research teams that are scaling up the implementation of the One Health approach. The selected projects will contribute to WHO’s 2021–2030 road map for neglected tropical diseases, the WHO Regional Office for Africa’s 2019–2029 strategic action plan to scale up health and environment Interventions in Africa, and its 2022-2032 updated regional strategy for the management of environmental determinants of human health in the WHO African Region.
There is a dynamic interaction between interventions to control and eradicate diseases caused by microbes (bacteria, viruses, fungi, parasites, etc.) and the vectors that often transmit them (mosquitoes, flies, snails, etc.). Over time, resistance to interventions can develop and reduce their effectiveness. Antimicrobial resistance, resistance to antiparasitic diseases and insecticide resistance now all pose significant global threats. TDR will support multisectoral research to inform national action plans and strategies to prevent and combat resistance. We will contribute to research that strengthens resilience through improved surveillance, better risk assessment, enhanced awareness and better understanding of underpinning human behaviour related to the spread of resistance.
Through SORT IT, TDR has been building sustainable operational research capacity to generate and utilize evidence to tackle the emergence, spread and health impact of antimicrobial resistance in low- and middle-income countries. This involves strong engagement with WHO country offices, antimicrobial resistance committees and SORT IT partners. Research priorities are tailored to national action plans and local needs.
TDR
World Health Organization
20, Avenue Appia
1211 Geneva 27
Switzerland
tdr@who.int
Visit our website: www.tdr.who.int
How to cite this document: World Health Organization & UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. (2023). TDR strategy 2024–2029: building local research solutions to improve global health. World Health Organization. https://apps.who.int/iris/handle/10665/371092. License: CC BY-NC-SA 3.0 IGO
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that the World Health Organization (WHO), including the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), endorses any specific organization, products or services. The use of WHO and TDR logos is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO) or by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). WHO, including TDR is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.
Suggested citation. TDR annual report 2022: building the science of solutions. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
Sales, rights and licensing. To purchase WHO publications, see https://www.who.int/publications/book-orders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/copyright.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO, including TDR, concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO, including TDR, in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO, including TDR, to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO, including TDR, be liable for damages arising from its use.